Locally Advanced/Metastatic/Recurrent ESCC

1

Review clinical trials related to Locally Advanced/Metastatic/Recurrent ESCC. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma

This study is a randomized, Controlled, Open-Label, Multicenter Phase Ⅲ Study of SYS6010 vs Investigator's Choice Single-Agent Chemotherapy in Locally Advanced/Metastatic/Recurrent ESCC Patients with Failure of At Least One Line of Systemic Therapy

Participants needed: 436
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.Updated: Feb 18, 2026
Eligibility criteria

Voluntarily sign the Informed Consent Form (ICF); [+8]

A past pathological diagnosis of esophageal cancer with adenocarcinoma, adenosqu... [+29]